Czene Kamila, Hemminki Kari
Department of Biosciences at Novum, Karolinska Institute, Huddinge, Sweden.
J Urol. 2003 Apr;169(4):1271-5. doi: 10.1097/01.ju.0000052373.36963.12.
Familial risks in papillary renal cell carcinoma and association with second primary malignancies were studied using the nationwide Swedish Family Cancer Data Base.
Cancer data obtained from the Swedish Cancer Registry from 1961 to 1998 included 1,733 cases of papillary renal cell carcinoma. The standardized incidence ratio was used to measure cancer risk.
Only 5 families were identified in which a parent had papillary renal cell carcinoma and an offspring had kidney cancer (nonsignificant SIR 1.51 for offspring). Discordant tumor sites associated with papillary renal cell carcinoma in the 2 generations were the upper aerodigestive tract and bladder (SIR 2.53, 95% CI 1.08 to 4.58 and 2.14, 95% CI 1.02 to 3.68, respectively). There was an overall increase in the risk of second primary malignancies of the lung, prostate and bladder and for non-Hodgkin's lymphoma and leukemia in patients with papillary renal cell carcinoma. The risk for a second primary tumor of the bladder associated with papillary renal cell carcinoma during the followup of 1 to 10 years was about 15 times higher than that associated with adenocarcinoma, which is the most common histological type of kidney cancer. The SIR was significantly higher in females than in males (59.67, 95% CI 40.23 to 82.94 versus 18.76, 95% CI 14.51 to 23.56).
In addition to the familial association of these 2 cancer sites, the high risk of a second primary cancer of the bladder in patients with papillary renal cell carcinoma may reflect a common genetic alteration.
利用瑞典全国性家庭癌症数据库研究乳头状肾细胞癌的家族风险及其与第二原发性恶性肿瘤的关联。
从瑞典癌症登记处获得的1961年至1998年的癌症数据包括1733例乳头状肾细胞癌病例。标准化发病比用于衡量癌症风险。
仅识别出5个家庭,其中父母患有乳头状肾细胞癌且子女患有肾癌(子女的标准化发病比为1.51,无统计学意义)。两代人中与乳头状肾细胞癌相关的不一致肿瘤部位为上消化道和膀胱(标准化发病比分别为2.53,95%可信区间1.08至4.58和2.14,95%可信区间1.02至3.68)。乳头状肾细胞癌患者发生肺、前列腺和膀胱第二原发性恶性肿瘤以及非霍奇金淋巴瘤和白血病的风险总体增加。在1至10年的随访期间,与乳头状肾细胞癌相关的膀胱第二原发性肿瘤风险比与腺癌(肾癌最常见的组织学类型)相关的风险高约15倍。女性的标准化发病比显著高于男性(59.67,95%可信区间40.23至82.94对18.76,95%可信区间14.51至23.56)。
除了这两个癌症部位的家族关联外,乳头状肾细胞癌患者发生膀胱第二原发性癌症的高风险可能反映了一种共同的基因改变。